tiprankstipranks
Trending News
More News >
Embellence Group AB (SE:EMBELL)
:EMBELL

Embellence Group AB (EMBELL) AI Stock Analysis

Compare
0 Followers

Top Page

SE:EMBELL

Embellence Group AB

(EMBELL)

Select Model
Select Model
Select Model
Outperform 71 (OpenAI - 5.2)
Rating:71Outperform
Price Target:
kr43.00
▲(6.17% Upside)
Score is driven primarily by solid financial performance, including strong margins and meaningfully improved leverage, supported by acceptable free cash flow. Valuation is reasonable with a decent dividend yield. Technicals are the main constraint, with largely neutral indicators and slightly negative momentum.
Positive Factors
High Gross and EBIT Margins
Sustained high gross (~61%) and healthy EBIT (~11.7%) margins suggest durable product-level pricing power and cost structure advantages in cosmetics. This margin base supports consistent operating profitability, reinvestment in R&D/brand, and resilience to input-cost shocks over months.
Improved Leverage and Strong Capital Structure
Material deleveraging (D/E ~0.27 vs ~0.70 in 2022) meaningfully lowers refinancing and interest-rate risk, improving financial flexibility. A stronger balance sheet supports strategic investment, M&A optionality, and steadier dividend or buyback policies over the medium term.
Supportive Free Cash Flow Generation
Robust FCF (~78m TTM, ~0.89x net income) indicates earnings translate into cash, supporting sustainable shareholder distributions, debt reduction, and capex without heavy external funding. Persistent FCF capacity enhances long-term capital allocation options.
Negative Factors
Revenue Essentially Flat vs 2024
Flat absolute revenue versus the prior year limits organic growth runway and suggests the business may rely on margin improvement rather than volume expansion. Over months, stagnant top-line constrains scalability, market-share gains, and long-term earnings upside absent new channels or products.
Volatile Operating Cash Flow and Cash Conversion
Significant OCF variability and a modest cash conversion (~0.51) point to working-capital swings that can unpredictably affect liquidity. This volatility reduces confidence in funding cadence for capex, dividends, or debt service and complicates multi-quarter financial planning.
Shrinking Asset Base and Lower ROE vs Peak
A declining asset base plus a material drop in ROE from prior peaks implies reduced reinvestment efficiency or slowing demand. Persistently lower ROE can constrain long-term shareholder returns and signal limits to growth unless operational or strategic initiatives reverse the trend.

Embellence Group AB (EMBELL) vs. iShares MSCI Sweden ETF (EWD)

Embellence Group AB Business Overview & Revenue Model

Company DescriptionEmbellence Group AB (publ) acquires, owns, and develops various brands in wallpapers, textiles, rugs, and other interior decoration items. The company offers its products under the Cole & Son, Wall&decò, Perswall, Pappelina, Artscape, and Boråstapeter brand names. It serves customers in Sweden, Norway, Italy, and the United Kingdom. The company was founded in 1905 and is headquartered in Borås, Sweden.
How the Company Makes MoneyEmbellence Group AB primarily generates revenue through the sale of its branded cosmetic products and private label solutions to retailers and distributors. The company's revenue model includes direct sales to consumers through e-commerce platforms and retail partnerships. Key revenue streams are derived from product sales in various segments, including skincare, haircare, and beauty accessories. EMBELL also benefits from strategic partnerships with retailers and online marketplaces that expand its distribution channels. Additionally, the company may engage in co-branding or collaborations with other beauty brands, enhancing its market reach and revenue potential.

Embellence Group AB Financial Statement Overview

Summary
Strong profitability (gross margin ~61%, EBIT margin ~11.7%) with stable-to-improving net margin (~8.3% TTM). Balance sheet risk has improved materially (debt-to-equity ~0.27 TTM vs ~0.70 in 2022), and ROE is healthy (~12%). Main offsets are flat revenue versus 2024 in absolute terms and somewhat variable cash conversion/operating cash flow.
Income Statement
78
Positive
TTM (Trailing-Twelve-Months) revenue growth is strong (+52%), and profitability is solid with a high gross margin (~61%) and healthy operating profitability (EBIT margin ~11.7%). Net margin is also stable-to-improving versus prior years (~8.3% TTM vs ~7.3% in 2024). The main weakness is that revenue is essentially flat versus 2024 on an absolute basis (TTM ~771m vs 2024 ~778m), and net margins have shown some variability over the cycle (notably lower in 2023), indicating results can be somewhat sensitive to demand or cost conditions.
Balance Sheet
82
Very Positive
Leverage has improved meaningfully: debt-to-equity has come down to ~0.27 in TTM (Trailing-Twelve-Months) from ~0.53 in 2023 and ~0.70 in 2022, suggesting a stronger capital structure and lower balance-sheet risk. Returns on equity are healthy (~12% TTM), though below the very strong levels seen in 2020–2021 (~20%). Equity remains sizable (~506m TTM), but total assets have drifted down from 2024 (784m TTM vs 830m in 2024), which may reflect a smaller asset base or working-capital swings rather than clear expansion.
Cash Flow
74
Positive
Cash generation is generally supportive: free cash flow is strong (78m TTM) and closely tracks earnings (free cash flow is ~0.89x net income TTM), indicating decent earnings quality. However, operating cash flow has been uneven (113m in 2024 vs 87.7m TTM), and the provided cash conversion indicator remains moderate (about 0.51 TTM), implying working-capital or timing effects can meaningfully swing cash results. Free cash flow growth is volatile across years (down in 2021 and 2023, then improving again), which slightly reduces confidence in consistency.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue771.00M778.00M740.47M720.10M646.88M569.86M
Gross Profit474.00M466.00M432.47M423.24M359.05M311.97M
EBITDA135.00M132.26M119.00M124.67M109.57M94.33M
Net Income64.00M57.00M39.29M57.40M59.31M43.13M
Balance Sheet
Total Assets784.00M830.00M801.76M853.18M623.46M513.08M
Cash, Cash Equivalents and Short-Term Investments37.00M40.57M37.90M66.23M57.99M49.01M
Total Debt136.00M139.00M242.25M277.72M183.03M140.70M
Total Liabilities278.00M292.00M386.89M454.12M330.09M301.31M
Stockholders Equity506.00M538.00M414.88M399.06M293.37M211.77M
Cash Flow
Free Cash Flow78.00M99.94M48.92M93.07M43.56M50.08M
Operating Cash Flow87.72M113.00M64.53M107.94M62.10M67.06M
Investing Cash Flow-14.55M-13.55M-16.19M-156.41M-53.23M-17.40M
Financing Cash Flow-81.58M-98.58M-77.80M54.21M-2.31M-33.04M

Embellence Group AB Technical Analysis

Technical Analysis Sentiment
Negative
Last Price40.50
Price Trends
50DMA
38.75
Negative
100DMA
38.68
Negative
200DMA
37.10
Negative
Market Momentum
MACD
-0.83
Positive
RSI
29.46
Positive
STOCH
3.60
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:EMBELL, the sentiment is Negative. The current price of 40.5 is above the 20-day moving average (MA) of 37.93, above the 50-day MA of 38.75, and above the 200-day MA of 37.10, indicating a bearish trend. The MACD of -0.83 indicates Positive momentum. The RSI at 29.46 is Positive, neither overbought nor oversold. The STOCH value of 3.60 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:EMBELL.

Embellence Group AB Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
kr835.62M13.0612.72%3.17%0.78%1.33%
70
Outperform
kr1.17B18.244.49%9.46%59.55%
69
Neutral
kr1.47B16.9923.44%4.95%9.20%11.72%
68
Neutral
kr1.31B21.7210.85%1.87%11.38%16.09%
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
56
Neutral
kr1.04B-173.66-0.32%5.49%-10.68%-103.85%
42
Neutral
kr60.88M-6.74-197.48%-10.50%99.53%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SE:EMBELL
Embellence Group AB
35.50
4.91
16.04%
SE:DSNO
Desenio Group AB
0.06
-0.18
-73.95%
SE:RUG
RugVista Group AB
63.00
17.45
38.32%
SE:BULTEN
Bulten AB
49.65
-16.64
-25.11%
SE:BORG
Bjorn Borg AB
58.60
6.11
11.63%
SE:BOKUS
Bokusgruppen AB
72.60
28.16
63.37%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 13, 2026